UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients

The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news